Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
Vale SA
VALE
KB Home
KBH
Apple
AAPL
US Stock MarketDetailed Quotes
MNPR Monopar Therapeutics
- 43.1000
- -1.5800-3.54%
Close Feb 14 16:00 ET
- 43.1000
- 0.00000.00%
Post 20:01 ET
263.02MMarket Cap-21.77P/E (TTM)
43.6016High39.7212Low57.68KVolume43.0000Open44.6800Pre Close2.46MTurnover1.46%Turnover RatioLossP/E (Static)6.10MShares54.300052wk High53.14P/B169.93MFloat Cap1.715052wk Low--Dividend TTM3.94MShs Float240.0000Historical High--Div YieldTTM8.69%Amplitude1.3695Historical Low42.5980Avg Price1Lot Size
About Monopar Therapeutics Company
Monopar Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing proprietary therapeutics for cancer patients. It also focuses on building a drug development pipeline through the licensing, and acquisition of therapeutics in late preclinical and clinical development stages. The company was founded by Chandler Drew Robinson, Christopher M. Starr and Andrew P. Mazar in December 2014 and is headquartered in Wilmette, IL.
Company Profile
SymbolMNPR
Company NameMonopar Therapeutics
Listing DateDec 19, 2019
Issue Price8.00
Founded2014
CEODr. Chandler D. Robinson, M. Sc.,M.B.A.,M.D.
MarketNASDAQ
Employees10
Fiscal Year Ends12-31
Address1000 Skokie Boulevard,Suite 350
CityWilmette
ProvinceIllinois
CountryUnited States of America
Zip Code60091
Phone1-847-388-0349
Websitehttp://www.monopartx.com
Company Executives
- Name
- Position
- Salary
- Dr. Chandler D. Robinson, M. Sc.,M.B.A.,M.D.
- Chief Executive Officer and Director
- 1.78M
- Andrew J. Cittadine
- Chief Operating Officer
- 911.14K
- Dr. Patrice P. Rioux,M.D.,PhD
- Acting Chief Medical Officer
- --
- Karthik Radhakrishnan
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Christopher M. Starr,PhD
- Executive Chairman of the Board
- 264.04K
- Kim R. Tsuchimoto
- Director
- 848.44K
- Raymond William Anderson, M.B.A.,M.S.
- Independent Director
- 136.54K
- Michael J. Brown, M. Sc.
- Independent Director
- 126.04K
- Arthur J. Klausner, M.B.A.
- Independent Director
- 128.54K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.